Galectin Therapeutics (GALT) Cash flow

668 Followers

Galectin Therapeutics Cash Flow

GALT's free cash flow for Q4 2025 was $-6.04M. For the 2025 fiscal year, GALT's free cash flow was decreased by $17.89M and operating cash flow was $-6.04M. See a summary of the company’s cash flow.

Cash Flow	Mar 26	Mar 25	Dec 23	Dec 22	Mar 22
Operating Cash Flow	$ -23.88M	$ -41.77M	$ -32.97M	$ -31.06M	$ -24.31M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 26.48M	$ 31.23M	$ 40.03M	$ 10.00M	$ 36.81M
End Cash Position	$ 17.72M	$ 15.12M	$ 25.66M	$ 18.59M	$ 39.65M
Free Cash Flow	$ -23.88M	$ -41.77M	$ -32.97M	$ -31.06M	$ -24.31M

Currency in USD